1,230
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Risk factors analysis for hyperuricemic nephropathy among CKD stages 3–4 patients: an epidemiological study of hyperuricemia in CKD stages 3–4 patients in Ningbo, China

, , , , &
Pages 665-670 | Received 22 Nov 2017, Accepted 07 Jun 2018, Published online: 29 Nov 2018

References

  • Jalal DI, Chonchol M, Chen W, et al. Uric Acid As A Target Of Therapy In CKD. Am J Kidney Dis. 2013;61:134–146.
  • Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens. 2009;18:526.
  • Tomczak J, Wasilewska A, Milewski R. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol. 2013;28:1863–1869.
  • Jin M, Yang F, Yang I. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656–669.
  • Ohno I. Relationship between hyperuricemia and chronic kidney disease. Nucleosides Nucleotides Nucleic Acids. 2011;30:1039–1044.
  • Liu N, Wang L, Yang T, et al. EGF receptor inhibition alleviates hyperuricemic nephropathy. J Am Soc Nephrol. 2015;26:2716–2729.
  • Huijuan W, Xiaoxu C, Rui S, et al. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats. Biomed Pharmacother. 2017;91:358–365.
  • Vázquez-Mellado J, Alvarez Hernández E, Burgos-Vargas R. Primary prevention in rheumatology: the importance of hyperuricemia. Best Pract Res Clin Rheumatol. 2004;18:111–124.
  • Wei CY, Sun CC, Wei CC. Association between hyperuricemia and metabolic syndrome: an epidemiological study of a labor force population in Taiwan. 2015;2015(7):369179.
  • Fu S, Luo L, Ye P, et al. Epidemiological associations between hyperuricemia and cardiometabolic risk factors: a comprehensive study from Chinese community. BMC Cardiovasc Disord. 2015;15:1–5.
  • Ren Z, Huang C, Momma H, et al. The consumption of fish cooked by different methods was related to the risk of hyperuricemia in Japanese adults: a 3-year follow-up study. Nutr Metab Cardiovasc Dis. 2016;26:778–785.
  • Mangala P, Silva CSD, Shameem K, et al. Urinary biomarkers KIM-1 and NGAL for detection of chronic kidney disease of uncertain etiology (CKDu) among agricultural communities in Sri Lanka. Plos Negl Trop Dis 2016;10: e0004979.
  • Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53:796–803.
  • Mok Y, Lee SJ, Kim MS, et al. Serum uric acid and chronic kidney disease: the Severance cohort study. Nephrol Dial Transplant. 2012;27:1831–1835.
  • Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010;56:264–272.
  • Cherian S, Crompton CH. Partial hypoxanthine-guanine phosphoribosyltransferase deficiency presenting as acute renal failure. Pediatr Nephrol. 2005;20:1811–1813.
  • Nepal M, Bock GH, Sehic AM, et al. Kidney injury molecule-1 expression identifies proximal tubular injury in urate nephropathy. Ann Clin Lab Sci. 2008;38:210–214.
  • Liu Y, sUN W, Zhang X, et al. Compound tufuling granules regulate glucose transporter 9 expression in kidney to influence serum uric acid level in hyperuricemia mice. Chin J Integr Med. 2015;21:823–829.
  • Xu WA, Yin L, Pan HY, et al. Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia. J Ethnopharmacol. 2013;150:747–754.
  • Wei S. Effects of herba of lysimachia christinae and its folk variety on hyperuricemia in mice. China Pharmaceuticals 2006;15:10–11.
  • Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol. 2004;15:164–173.
  • Chen GL, Zhu LR, Na S, et al. Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats. Zhongguo Zhong Yao Za Zhi 2013;38:2348–2353.
  • Hao X, Liu X, Wang W, et al. Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics. PLoS One. 2013;8:e78531.
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–470.
  • Stürenburg E, Kramer J, Schön G, et al. Detection of significant bacteriuria by use of the iQ200 automated urine microscope. J Clin Microbiol. 2014;52:2855–2860.
  • Al-Arfaj AS. Hyperuricemia in Saudi Arabia. Rheumatol Int. 2001;20:61–64.
  • Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–650.
  • Toprak O, Cirit M, Esi E, et al. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006;67(2):227–235.
  • Sperling O. Renal hypouricemia, hereditary. Berlin Heidelberg: Springer; 2009.
  • Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum. 2004;50:2400–2414.